ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JULY 2024

News provided by

Aug 05, 2024, 06:21 ET

Zinzino group revenue increased with a total of 13 %, compared with the previous year.

GOTHENBURG, Sweden, Aug. 5, 2024 /PRNewswire/ -- The revenue in July for Zinzino's sales markets increased by 10 % and amounted to SEK 159.3 (145.0) million. Faun Pharma's external sales increased by 91 % and amounted to SEK 10.3 (5.4) million. Overall, the Group increased revenues by 13 % to SEK 169.9 (150.4) million compared with the previous year.

Accumulated revenue for January – July 2024 increased by 19 % to SEK 1131.2 (952.0) million.

Revenues were distributed as follows:

Regions,MSEK	24-Jul	23-Jul	Change	YTD 2024	YTD 2023	Change
The Nordics	23.4	23.5	0 %	165.0	168.3	-2 %
Central Europe	44.0	41.4	6 %	299.8	232.6	29 %
East Europe	29.4	35.2	-16 %	221.0	222.2	-1 %
South & West Europe	33.3	23.3	43 %	193.6	134.8	44 %
The Baltics	8.1	9.2	-12 %	55.6	51.9	7 %
North America	16.9	7.3	132 %	98.2	46.4	112 %
Asia-Pacific	2.8	4.1	-32 %	28.2	34.1	-17 %
Africa	1.4	1.0	40 %	8.3	8.1	2 %
Zinzino	159.3	145.0	10 %	1069.7	898.4	19 %
Faun Pharma	10.3	5.4	91 %	61.5	53.6	15 %
Zinzino Group	169.6	150.4	13 %	1131.2	952.0	19 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa